The antitumor activity of meisoindigo against human colorectal cancer HT-29 cells in vitro and in vivo.
Zuo Mingxin , Li Yan , Wang Hongbo , Zhou Jianhua
Journal of Chemotherapy 20 ( 6) 728 -733
35
2008
The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma
Chen Liu , Rachid Karam , YingQi Zhou , Fang Su
Nature Medicine 20 ( 6) 596 -598
75
2014
Biliary cancer: Utility of next-generation sequencing for clinical management.
Milind Javle , Tanios Bekaii-Saab , Apurva Jain , Ying Wang
Cancer 122 ( 24) 3838 -3847
120
2016
Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
Li Lin , Brian Hutzen , Mingxin Zuo , Sarah Ball
Cancer Research 70 ( 6) 2445 -2454
169
2010
HER2/neu-directed therapy for biliary tract cancer.
Humaid Obaid Al-Shamsi , Christian Daniel Barrera , Rakesh Surapaneni , HyunSeon Kang
Journal of Clinical Oncology 33
1
2015
Activity of FB2, a novel dual Abl/Src tyrosine kinase inhibitor, against imatinib-resistant chronic myeloid leukemia in vivo and in vitro
He Liu , Hongyan Li , Zhiqiang Feng , Jun Tai
Leukemia & Lymphoma 50 ( 3) 437 -446
5
2009
Tumor mutational burden (TMB) and co-existing actionable mutations in biliary tract cancers (BTC).
Apurva Jain , Rachna T. Shroff , Mingxin Zuo , Jacqueline Weatherly
Journal of Clinical Oncology 35 ( 15_suppl) 4086 -4086
4
2017
A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.
Li Lin , Brian Hutzen , Pui-Kai Li , Sarah Ball
Neoplasia 12 ( 1) 39 -50
160
2010
LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy
Mingxin Zuo , Chenglong Li , Jiayuh Lin , Milind Javle
Oncotarget 6 ( 13) 10940 -10949
24
2015
RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer
Mingxin Zuo , Asif Rashid , Ying Wang , Apurva Jain
Oncotarget 7 ( 23) 35302 -35312
13
2016
BAP1 mutation-associated cholangiocarcinoma: An aggressive disease.
Deepa Anand , Chaitanya Churi , Asif Rashid , Rachna T. Shroff
Journal of Clinical Oncology 33 420 -420
1
2015
Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
Chaitanya R. Churi , Rachna Shroff , Ying Wang , Asif Rashid
PLoS ONE 9 ( 12) e115383
392
2014
BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtype
Humaid O. Al-Shamsi , Deepa Anand , Rachna T. Shroff , Apurva Jain
Journal of gastrointestinal oncology 7 ( 4) 556 -561
15
2016
HER2/neu-directed therapy for biliary tract cancer
Milind Javle , Chaitanya Churi , HyunSeon C. Kang , Rachna Shroff
Journal of Hematology & Oncology 8 ( 1) 58 -58
125
2015
Variations in DNA repair genomic alterations and tumor mutation burden in biliary tract cancer (BTC) subtypes.
Reham Abdel-Wahab , Siraj Mahamed Ali , Mitesh J. Borad , Rachna T. Shroff
Journal of Clinical Oncology 36 ( 4_suppl) 263 -263
17
2018
Molecular characterization of gallbladder cancer using somatic mutation profiling.
Milind Javle , Asif Rashid , Chaitanya Churi , Siddhartha Kar
Human Pathology 45 ( 4) 701 -708
51
2014
Abstract# 3721: A novel small molecule exhibits potent growth suppressive activity through the inhibition of constitutive JAK2/STAT3 signaling in breast cancer, pancreatic cancer, and glioblastoma cells.
Li Lin , Brian Hutzen , Sarah Ball , Elizabeth Foust
Cancer Research 69 ( 9_Supplement) 3721 -3721
2009
DNA repair genetic aberrations and tumor mutation burden in biliary tract cancers
Reham Abdel-Wahab , Rachna Shroff , Jean Nicolas Vauthey , Eugene Jon Koay
JOURNAL FOR IMMUNOTHERAPY OF CANCER 5
2017
Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer
M Zuo , A Rashid , C Churi , J-N Vauthey
British Journal of Cancer 112 ( 6) 1042 -1051
25
2015
A NOVEL SMALL MOLECULE EXHIBITS POTENT GROWTH SUPPRESSIVE ACTIVITY THROUGH THE INHIBITION OF CONSTITUTIVE JAK2/STAT3 SIGNALING IN HUMAN CANCER CELLS
J Lin , L Lin , B Hutzen , S Ball
ANNALS OF ONCOLOGY 20 20 -20
2009